Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Directed in Vitro Evolution of Therapeutic Bacteriophages: The Appelmans Protocol.

Burrowes BH, Molineux IJ, Fralick JA.

Viruses. 2019 Mar 11;11(3). pii: E241. doi: 10.3390/v11030241.

2.

Evidence that the C-terminal region is involved in the stability and functionality of OprM in E. coli.

Bai J, Bhagavathi R, Tran P, Muzzarelli K, Wang D, Fralick JA.

Microbiol Res. 2014 May-Jun;169(5-6):425-31. doi: 10.1016/j.micres.2013.08.006. Epub 2013 Oct 18.

3.

Xenobiotic efflux in bacteria and fungi: a genomics update.

Barabote RD, Thekkiniath J, Strauss RE, Vediyappan G, Fralick JA, San Francisco MJ.

Adv Enzymol Relat Areas Mol Biol. 2011;77:237-306. Review. No abstract available.

4.

In vivo lysogenization of a Clostridium difficile bacteriophage ФCD119.

Revathi G, Fralick JA, Rolfe RD.

Anaerobe. 2011 Jun;17(3):125-9. doi: 10.1016/j.anaerobe.2011.05.012. Epub 2011 Jun 2.

5.

Evidence that the C-terminus of OprM is involved in the assembly of the VceAB-OprM efflux pump.

Bai J, Mosley L, Fralick JA.

FEBS Lett. 2010 Apr 16;584(8):1493-7. doi: 10.1016/j.febslet.2010.02.066. Epub 2010 Mar 3.

6.

Bacteriophage-mediated toxin gene regulation in Clostridium difficile.

Govind R, Vediyappan G, Rolfe RD, Dupuy B, Fralick JA.

J Virol. 2009 Dec;83(23):12037-45. doi: 10.1128/JVI.01256-09. Epub 2009 Sep 23.

7.

Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model.

McVay CS, Velásquez M, Fralick JA.

Antimicrob Agents Chemother. 2007 Jun;51(6):1934-8. Epub 2007 Mar 26.

9.

Evidence that Clostridium difficile TcdC is a membrane-associated protein.

Govind R, Vediyappan G, Rolfe RD, Fralick JA.

J Bacteriol. 2006 May;188(10):3716-20.

10.
11.

Characterization of the Vibrio cholerae vceCAB multiple-drug resistance efflux operon in Escherichia coli.

Woolley RC, Vediyappan G, Anderson M, Lackey M, Ramasubramanian B, Jiangping B, Borisova T, Colmer JA, Hamood AN, McVay CS, Fralick JA.

J Bacteriol. 2005 Aug;187(15):5500-3.

12.

Erwinia chrysanthemi tolC is involved in resistance to antimicrobial plant chemicals and is essential for phytopathogenesis.

Barabote RD, Johnson OL, Zetina E, San Francisco SK, Fralick JA, San Francisco MJ.

J Bacteriol. 2003 Oct;185(19):5772-8.

13.

Is DnaA the 'pace-maker' of chromosome replication? An old paper revisited.

Fralick JA.

Mol Microbiol. 1999 Feb;31(3):1011-2. No abstract available.

14.

Isolation and characterization of a putative multidrug resistance pump from Vibrio cholerae.

Colmer JA, Fralick JA, Hamood AN.

Mol Microbiol. 1998 Jan;27(1):63-72.

16.
18.

Isolation of an Lc-specific Escherichia coli bacteriophage.

Fralick JA, Diedrich DL, Casey-Wood S.

J Bacteriol. 1990 Mar;172(3):1660-2.

20.

Studies on the expression of outer membrane protein 2 in escherichia coli.

Fralick JA, Diedrich DL.

Mol Gen Genet. 1982;188(1):139-42.

PMID:
6757670
22.
23.

Studies on the regulation of initiation of chromosome replication in Escherichia coli.

Fralick JA.

J Mol Biol. 1978 Jul 5;122(3):271-86. No abstract available.

PMID:
357730
24.

Evidence for the involvement of unsaturated fatty acids in initiating chromosome replication in Escherichia coli.

Fralick JA, Lark KG.

J Mol Biol. 1973 Nov 5;80(3):459-75. No abstract available.

PMID:
4586983
25.

Membrane association of conjugally transferred deoxyribonucleic acid in Escherichia coli minicells.

Shull FW Jr, Fralick JA, Stratton LP, Fisher WD.

J Bacteriol. 1971 May;106(2):626-33.

26.

Polyuridylic acid-directed phenylalanine incorporation in minicell extracts.

Fralick JA, Fisher WD, Adler HI.

J Bacteriol. 1969 Aug;99(2):621-2.

Supplemental Content

Loading ...
Support Center